Yanjie Zhao

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Advanced Non Small Cell Lung Cancer

Sentinel Lymph Node

Signaling Pathway

Top Venues

Cancer management and research

OncoTargets and therapy

Breast cancer (Dove Medical Press)

This page only lists publications with an associated author ORCID identifier.

Publications

Ruibin Wang, Yanjie Zhao
Effects of Metformin on JNK Signaling Pathway and PD-L1 Expression in Triple Negative Breast Cancer. Cancer management and research 16 (2024)
Ruibin Wang, Yanjie Zhao
Effects of Metformin on JNK Signaling Pathway and PD-L1 Expression in Triple Negative Breast Cancer. Cancer management and research 16 (2024)
Yanjie Zhao, Ruibin Wang, Feng Shi, Jiangping Wu, Fusheng Jiang, Qing-Kun Song
Diagnostic Efficacy of CT Examination on Early Detection of Lung Cancer during Pandemic of COVID-19. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Ruibin Wang, Yu-Chen Li, Yanjie Zhao, Feng Shi, Quan Zhou, Jiangping Wu, Shuzhen Lyu, Qing-Kun Song
Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer. Breast cancer (Dove Medical Press) 14 (2022)
Yanjie Zhao, Feng Shi, Quan Zhou, Yuchen Li, Jiangping Wu, Ruibin Wang, Qingkun Song
Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma. Medicine 99 (45) (2020)
Feng Shi, Shuo Xiao, Kaeli B Miller, Yanjie Zhao, Yu-Chen Li, Ying Gao, Hong Chang, Qingkun Song, Chenxu Qu
Interactive Effects of PD-L1 Expression in Tumor and Immune Cells on Prognosis of Esophageal Squamous Cell Carcinoma: A One-Center Retrospective Cohort Study. OncoTargets and therapy 13 (2020)